Sarah Jessica Parker Blasts EpiPen Over Outrageous Price Hike

Kaitlan Collins Contributor
Font Size:

Sarah Jessica Parker blasted the company that manufactures EpiPens after it raised the price of the drug by nearly 500 percent over the last seven years.

(Photo: Neilson Barnard/Getty Images)

(Photo: Neilson Barnard/Getty Images)

The actress, who is a paid spokesman for the company Mylan, said she was ending her relationship with the company because of its sharp price hike.

A photo posted by SJP (@sarahjessicaparker) on

“I was recently involved in an initiative to raise awareness for anaphylaxis,” Parker wrote on Instagram Thursday. “It’s a cause deeply important to me because of my son’s life-threatening peanut allergy. The epinephrine auto-injector is a vital part of our family’s healthcare, as it is for the many who are at risk.”

“I recently learned that the price of the Epi-Pen has been systematically raised by Mylan to a point that renders the medication cost-prohibitive for countless people. I’m left disappointed, deeply saddened and deeply concerned with Mylan’s actions.”

“I do not condone this decision and I have ended my relationship with Mylan as a direct result of it.”

There is no generic equivalent and no brand-name competitor for the EpiPen.